Fuller & Thaler Asset Management’s Veracyte VCYT Stock Holding History

Fuller & Thaler Asset Management’s Portfolio VCYT Stock Details VCYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$88.7M	Buy	1,509,749 +95,387	+7%	+$4M	0.24%	145
2026 Q1	$45.6M	Buy	1,414,362 +32,925	+2%	+$1.22M	0.15%	209
2025 Q4	$58.2M	Buy	+1,381,437	New	+$55.7M	0.2%	184
2023 Q1	–	Sell	-372,185	Closed	-$8.83M	–	547
2022 Q4	$8.83M	Buy	+372,185	New	+$8.65M	0.06%	224
2019 Q3	–	Sell	-103,040	Closed	-$2.94M	–	493
2019 Q2	$2.94M	Sell	103,040 -51,152	-33%	-$1.28M	0.03%	246
2019 Q1	$3.86M	Buy	154,192 +4,680	+3%	+$89.4K	0.05%	209
2018 Q4	$1.88M	Buy	+149,512	New	+$1.77M	0.03%	274

Other funds holding VCYT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Fuller & Thaler Asset Management's VCYT Position: Q2 2026 in Review

Fuller & Thaler Asset Management increased its Veracyte (VCYT) stake by 6.7% in Q2 2026, buying an estimated $4M and bringing the position to 1,509,749 shares worth $88.7M. The position accounts for 0.24% of the portfolio, ranked #145.

Fuller & Thaler Asset Management first reported a position in VCYT in Q4 2018 and has held it in 7 quarters since. 371 funds tracked by Wall St. Rank hold VCYT as of Q2 2026.

Fuller & Thaler Asset Management held 1,509,749 shares of Veracyte worth $88.7M as of Q2 2026.
Fuller & Thaler Asset Management bought 95,387 Veracyte shares in Q2 2026, an estimated $4M.
Veracyte made up 0.24% of Fuller & Thaler Asset Management's portfolio in Q2 2026, its #145 holding.
Fuller & Thaler Asset Management first reported a position in Veracyte in Q4 2018 and has held it in 7 quarters since.
371 funds tracked by Wall St. Rank held Veracyte as of Q2 2026.

Based on Fuller & Thaler Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.